Neuroderm, the Israeli pharmaceutical company that deals with “next-generation treatments” was just bought for $1.1B in cash by Mitsubishi Tanabe Pharma
By i24NEWS
Israeli pharmaceutical company Neuroderm has been bought out in a massive deal for $1.1 billion by Japan’s Mitsubishi Tanabe Pharma Corp, the company announced on Monday.
The all-cash deal will expand the company’s business overseas, according to Reuters.
Medical student conducting research – Photo: Tel Aviv University’s Sackler School of Medicine
NeuroDerm develops drugs and medical devices for central nervous system (CNS) disorders such as Parkinson’s, in which it was the first to develop a key treatment currently used for the disease. Continue Reading »
Israeli New Shekel Exchange Rate